Microbiota, Oxidative Stress and Epithelial Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: 15 May 2024 | Viewed by 306
Special Issue Editors
Interests: lipid peroxidation; oxidative stress; cancer; chemoresistance; resistance to targeted therappies; melanoma; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: non-melanoma skin cancer; head and neck squamous cell carcinoma; probiotics; prebiotics and postbiotics; S. aureus; P. gingivalis; F. nucleatum; P. aeruginosa; S. mutans; S. mitis
Special Issue Information
Dear Colleagues,
We are pleased to serve as Guest Editors for the new Special Issue "Microbiota, Oxidative Stress and Epithelial Diseases."
Mounting evidence demonstrates the important role of oxidative stress in the pathogenesis of several medical conditions, including epithelial diseases. Elevated reactive oxygen species (ROS) can contribute, with different mechanisms, to their transformation and tumoral progression, including non-melanoma skin cancer, melanoma, head and neck squamous cell carcinoma, genital, colon, or breast malignancies. Moreover, several chronic benign inflammatory conditions involving epithelial tissues, such as atopic dermatitis, psoriasis, inflammatory bowel disease, or asthma, are associated with oxidative stress.
In the last few decades, microbiota has been identified as a major player in several human pathological conditions. Indeed, microbiota unbalance, named dysbiosis, is associated with the onset, progression, relapse, and resistance to therapies in several epithelial cancers. Moreover, alteration of the microbiota niches is closely linked to the pathogenesis of several inflammatory epithelial diseases.
It is well-known that dysbiosis can be associated with oxidative stress and/or inflammation. However, although their interplay has been somewhat suggested, the connection between microbiota, oxidative stress, and epithelial diseases is still a largely unexplored field.
This Special Issue welcomes original research and literature reviews concerning the connection between microbiota and oxidative stress in epithelial diseases.
Dr. Stefania Pizzimenti
Dr. Barbara Azzimonti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microbiota
- oxidative stress
- epithelial diseases
- non-melanoma skin cancer
- melanoma
- head and neck squamous cell carcinoma
- breast, genital, colon or other epithelial cancers
- atopic dermatitis or other skin inflammatory conditions
- inflammatory bowel disease
- asthma
